Back to search

Georgia Institute of Technology

Engineering fusion protein vesicles for biocatalysis and drug delivery applications

Abstract

dc:description.abstract

Since liposomes were first discovered in 1964, vesicles have been investigated as carriers for drug delivery, artificial organelles in synthetic biology, and microreactors for generation of commodity chemicals. This research has led to the development of 18 FDA approved formulations of liposomes, artificial organelles that can complete complex biological processes like cell-free ATP generation, and development of novel microreactors that can improve yield of certain biocatalytic processes. A majority of the vesicles involved in these developments have been synthesized from lipids as they were first discovered in 1964. In 1995, vesicles were made from polymer building blocks, which have been shown to have enhanced mechanical properties and circulation time compared to some lipid vesicles. However, these polymers lack biocompatibility and the synthesis methods of lipid and polymer blocks often includes first dissolving these macromolecules in solvents, which can be deleterious to their functionality and impact biocompatibility. The advances in recombinant DNA technology and protein engineering have improved researchers’ ability to study protein function and even predict protein folding. With the continued rapid development of fusion protein technology, it has become more practical to make protein-based nanoparticles. Vesicles made from proteins were first reported in 2012. These vesicles offer enhanced tunability and functionality compared to liposomes while also retaining inherent biocompatibility. Here, we study vesicles made from modular fusion protein components. Each component plays a unique and important role in the self-assembly of the vesicles. In this thesis, the modular components are varied systematically to determine the effects of each one of the modular components on vesicle self-assembly. Then, we demonstrated vesicle self-assembly from enzymes involved in synthesis of chiral amines as a proof of concept for biosynthesis of pharmaceutically relevant molecules using vesicles as supports.

Degree

thesis:*
Level thesis:degree_level
Doctoral
Department dc:contributor.department
Chemical and Biomolecular Engineering
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Dautel, Dylan R.
Advisor dc:contributor.advisor
  • Champion, Julie A.
Committee members dc:contributor.committeemember
  • Behrens, Sven
  • Wilson, Corey J.
  • Bommarius, Andreas
  • Peralta-Yahya, Pamela

Subjects

dc:subject × 3

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1853/72463

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Dautel, Dylan R.. Engineering fusion protein vesicles for biocatalysis and drug delivery applications. Doctoral thesis, Georgia Institute of Technology, 2022. https://hdl.handle.net/1853/72463